Validity and Reliability of SCIM-SR
October 23, 2024 updated by: Yelda Soluk Özdemir, Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Validity and Reliability of the Turkish Version of the Spinal Cord Independence Measure Self-Report
To determine the validity and reliability of SCIM-SR, patients will fill out SCIM 3 and SR.
Study Overview
Detailed Description
To determine the validity and reliability of SCIM-SR, patients will fill out SCIM 3 and SR.
scım-sr Turkish form has been created.
Patients with spinal cord injuries who applied to our physical therapy clinic filled out the form twice.
Study Type
Observational
Enrollment (Actual)
90
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
None Selected
-
Istanbul, None Selected, Turkey, 34147
- Cansın Medin Ceylan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
-SCI patients between the ages of 18-70 and at least 1 month after their injury
Description
Inclusion Criteria:
- SCI >1 month
- 18-70 years
- agree to participate
- give written consent
Exclusion Criteria:
- not read Turkish,
- not write Turkish,
- cognitive problems
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
SCIM-SR
Time Frame: baseline
|
scım-sr was a self-reported scale that evaluated the independence of patients.
|
baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 16, 2023
Primary Completion (Actual)
June 16, 2024
Study Completion (Actual)
July 16, 2024
Study Registration Dates
First Submitted
October 22, 2024
First Submitted That Met QC Criteria
October 23, 2024
First Posted (Actual)
October 24, 2024
Study Record Updates
Last Update Posted (Actual)
October 24, 2024
Last Update Submitted That Met QC Criteria
October 23, 2024
Last Verified
October 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023/385
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.